Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.590
+0.035 (1.37%)
At close: Sep 4, 2026, 4:00 PM EDT
2.580
-0.010 (-0.39%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Compugen Revenue
Compugen had revenue of $2.60M in the quarter ending June 30, 2026, with 107.00% growth. This brings the company's revenue in the last twelve months to $74.00M, up 234.18% year-over-year. In the year 2025, Compugen had annual revenue of $72.76M with 161.14% growth.
Revenue (ttm)
$74.00M
Revenue Growth
+234.18%
P/S Ratio
3.32
Revenue / Employee
$986,680
Employees
75
Market Cap
245.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.76M | 44.90M | 161.14% |
| Dec 31, 2024 | 27.86M | -5.60M | -16.72% |
| Dec 31, 2023 | 33.46M | 25.96M | 346.12% |
| Dec 31, 2022 | 7.50M | 1.50M | 25.00% |
| Dec 31, 2021 | 6.00M | 4.00M | 200.00% |
| Dec 31, 2020 | 2.00M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 17.80M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 712.00K | -8.57M | -92.33% |
| Dec 31, 2015 | 9.28M | -3.09M | -24.99% |
| Dec 31, 2014 | 12.37M | 8.82M | 248.46% |
| Dec 31, 2013 | 3.55M | 3.31M | 1,366.53% |
| Dec 31, 2012 | 242.00K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 1.12M | 865.00K | 346.00% |
| Dec 31, 2009 | 250.00K | -88.00K | -26.04% |
| Dec 31, 2008 | 338.00K | 158.00K | 87.78% |
| Dec 31, 2007 | 180.00K | -35.00K | -16.28% |
| Dec 31, 2006 | 215.00K | -431.00K | -66.72% |
| Dec 31, 2005 | 646.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Niagen Bioscience | 129.08M |
| Cellectis | 63.82M |
| Invivyd | 58.37M |
| Atrium Therapeutics | 35.84M |
| Adagene | 9.29M |
| Entrada Therapeutics | 4.69M |
| Camp4 Therapeutics | 4.22M |
| YD Bio | 510.36K |
CGEN News
- 4 weeks ago - Compugen Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Compugen Earnings release: Q2 2026 - Filings
- 4 weeks ago - Compugen reports Q2 EPS (7c), consensus (9c) - TheFly
- 4 weeks ago - Compugen Reports Second Quarter 2026 Results - PRNewsWire
- 4 weeks ago - Compugen Slides: Corporate presentation - Filings
- 6 weeks ago - Compugen to Participate in BTIG Biotechnology Conference 2026 - PRNewsWire
- 6 weeks ago - Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026 - PRNewsWire
- 1 month ago - Compugen management to meet virtually with Lake Street - TheFly